SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001539497-24-000604
Filing Date
2024-03-01
Accepted
2024-03-01 15:13:45
Documents
1
Effectiveness Date
2024-03-01

Document Format Files

Seq Description Document Type Size
1 15-12G n3936_x25-1512g.htm 15-12G 11100
  Complete submission text file 0001539497-24-000604.txt   12240
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 001-36783 | Film No.: 24709106
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)